Nautilus Neurosciences - CAMBIA® - Ownership and Business Overview

Medical ProductsCompany

Nautilus Neurosciences - CAMBIA® Ownership

Who owns Nautilus Neurosciences - CAMBIA®?

Nautilus Neurosciences - CAMBIA® is owned by Assertio Holdings. It was acquired on December 17, 2013.

Nautilus Neurosciences - CAMBIA® Business Overview

Where is Nautilus Neurosciences - CAMBIA® headquartered?

Nautilus Neurosciences - CAMBIA® is headquartered in United States.

What sector is Nautilus Neurosciences - CAMBIA® in?

Nautilus Neurosciences - CAMBIA® is a medical products company.

Medical Products M&A Summary in 2013

Out of 60 sectors in the Mergr database, medical products ranked 10 in number of deals in 2013. The largest medical products acquisition in 2013 was Bausch & Lomb - which was acquired by Bausch Health Companies for $8.7B.

Join Mergr to view all 195 acquisitions of medical products companies in 2013, including 28 acquisitions by private equity firms, and 167 by strategics.

Nautilus Neurosciences - CAMBIA® (Diclofenac Potassium for Oral Solution)


United States,

Nautilus Neurosciences - CAMBIA® (Diclofenac Potassium for Oral Solution) is a non-steroidal anti-inflammatory drug (NSAID) indicated for acute treatment of migraine attacks with or without aura in adults 18 years of age or older.


 Subscribe to unlock this and 202,409
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 194K M&A Transactions
  • 198K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Nautilus Neurosciences - CAMBIA®

Medical Products Companies , United States Companies